Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Previously Treated Small Cell Lung Cancer
NCT01470248Phase 2Completed
- Sponsor
- Emory University
- Start
- Aug 2011
- Primary completion
- Jan 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in small cell lung cancer (SCLC), sponsored by Emory University. Started Aug 2011; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01470248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470248.